Big news for acromegaly!

San Diego, California-based Crinetics Pharmaceutical announced today that its novel investigational drug paltusotine maintained IGf-1 levels in patients who switched from monthly injectables

Developing a new drug for acromegaly

As we reported earlier this year, the acromegaly new drug development world has seen very exciting activity. Several studies are in the pipeline for oral therapies.  Today, San Diego California based Crinetics Pharmaceuticals announced a new